EUVIMEDEUVIMED entdecken
Open Access

The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib

Wenxia Wang, Swati Bhattacharyya iD, Roberta Goncalves Marangoni, Mary Carns, Kathleen Dennis-Aren, Anjana Yeldandi, Jun Wei, John Varga

Journal of Scleroderma and Related Disorders · 2020-02 · 5 (1) · 40-50

DOI: 10.1177/2397198319865367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Scleroderma and Related Disorders, online erschienen am 07.08.2019. Verfasst von Wenxia Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern Scleroderma Program, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Scleroderma Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

Fibrosis leads to failure of the skin, lungs, and other organs in systemic sclerosis; accounts for substantial morbidity and mortality; and lacks effective therapy. Myofibroblast activation underlies organ fibrosis, but the key extracellular cues driving persistence of the process remain incompletely characterized.

Objectives

The objectives were to evaluate activation of the IL6/JAK/STAT axis associated with fibrosis in skin and lung biopsies from systemic sclerosis patients and effects of the Food and Drug Administration–approved JAK/STAT inhibitor, tofacitinib, on skin and lung fibrosis in animal models.

Methods

Bioinformatic analysis showed that IL6/JAK/STAT3 and tofacitinib gene signatures were aberrant in biopsies from systemic sclerosis patients in four independent cohorts. The results were confirmed by JAK and STAT3 phosphorylation in both skin and lung biopsies from patients with systemic sclerosis. Furthermore, treatment of mice with the selective JAK inhibitor tofacitinib not only prevented bleomycin-induced skin and lung fibrosis but also reduced skin fibrosis in TSK1/+ mice.

Conclusion

These findings implicate the JAK/STAT pathway in systemic sclerosis skin and lung fibrosis and identify tofacitinib as a potential antifibrotic agent for the treatment of systemic sclerosis and other fibrotic diseases.

Schlagwörter

Stichwörter der Autor:innen

JAKSTAT3Tofacitinibfibrosisinterleukin 6systemic sclerosis

Autor:innen und Institutionen

  • Northwestern Scleroderma Program, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Department of Surgical Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

ORCID-Profile: Swati Bhattacharyya

Förderung

  • NIAMS NIH HHS
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • Scleroderma Foundation
  • pfizer

Zitieren

APA

Wang, W., Bhattacharyya, S., Marangoni, R. G., Carns, M., Dennis-Aren, K., Yeldandi, A., Wei, J., & Varga, J. (2020). The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib. Journal of Scleroderma and Related Disorders, 5(1), 40-50. https://doi.org/10.1177/2397198319865367

Vancouver

Wang W, Bhattacharyya S, Marangoni RG, Carns M, Dennis-Aren K, Yeldandi A, et al. The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib. Journal of Scleroderma and Related Disorders. 2020;5(1):40-50. doi:10.1177/2397198319865367

BibTeX
@article{Wang2020,
  author = {Wang, Wenxia and Bhattacharyya, Swati and Marangoni, Roberta Goncalves and Carns, Mary and Dennis-Aren, Kathleen and Yeldandi, Anjana and Wei, Jun and Varga, John},
  title = {The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib},
  journal = {Journal of Scleroderma and Related Disorders},
  year = {2020},
  volume = {5},
  number = {1},
  pages = {40--50},
  doi = {10.1177/2397198319865367}
}
Kostenlos starten →